協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/09/16 | 2,438 | 2,444 | 2,395 | 2,400 | -49 | -2% | 1,668,600 |
2025/09/12 | 2,460 | 2,484.5 | 2,438.5 | 2,449 | -33 | -1.3% | 2,173,900 |
2025/09/11 | 2,510 | 2,519.5 | 2,473.5 | 2,482 | -51 | -2% | 1,491,500 |
2025/09/10 | 2,550 | 2,553 | 2,512.5 | 2,533 | -33 | -1.3% | 1,910,100 |
2025/09/09 | 2,594.5 | 2,618.5 | 2,553 | 2,566 | -35 | -1.3% | 1,003,200 |
2025/09/08 | 2,636 | 2,646.5 | 2,590.5 | 2,601 | -19 | -0.7% | 1,250,300 |
2025/09/05 | 2,630 | 2,632.5 | 2,607 | 2,620 | -18.5 | -0.7% | 896,900 |
2025/09/04 | 2,632 | 2,646 | 2,617 | 2,638.5 | +7 | +0.3% | 550,500 |
2025/09/03 | 2,637 | 2,643.5 | 2,623 | 2,631.5 | -2.5 | -0.1% | 800,800 |
2025/09/02 | 2,605 | 2,637.5 | 2,596 | 2,634 | +29 | +1.1% | 731,600 |
2025/09/01 | 2,565 | 2,605 | 2,546.5 | 2,605 | +60 | +2.4% | 616,500 |
2025/08/29 | 2,544 | 2,558 | 2,539.5 | 2,545 | +1 | ±0% | 612,500 |
2025/08/28 | 2,555 | 2,558 | 2,542.5 | 2,544 | -6 | -0.2% | 570,200 |
2025/08/27 | 2,562 | 2,564.5 | 2,525 | 2,550 | -16 | -0.6% | 622,800 |
2025/08/26 | 2,600 | 2,602 | 2,565.5 | 2,566 | -45 | -1.7% | 1,105,000 |
2025/08/25 | 2,620.5 | 2,635 | 2,602.5 | 2,611 | -28 | -1.1% | 507,000 |
2025/08/22 | 2,630.5 | 2,653 | 2,627.5 | 2,639 | +8.5 | +0.3% | 413,800 |
2025/08/21 | 2,637 | 2,651.5 | 2,607.5 | 2,630.5 | -19.5 | -0.7% | 672,200 |
2025/08/20 | 2,675 | 2,677 | 2,642.5 | 2,650 | -4.5 | -0.2% | 638,400 |
2025/08/19 | 2,630 | 2,660 | 2,626 | 2,654.5 | +22.5 | +0.9% | 659,200 |
2025/08/18 | 2,650 | 2,676 | 2,630 | 2,632 | -1 | ±0% | 528,800 |
2025/08/15 | 2,656.5 | 2,658 | 2,626.5 | 2,633 | +3 | +0.1% | 480,700 |
2025/08/14 | 2,649 | 2,659 | 2,628.5 | 2,630 | -1 | ±0% | 436,000 |
2025/08/13 | 2,621 | 2,641.5 | 2,612.5 | 2,631 | +11 | +0.4% | 779,200 |
2025/08/12 | 2,658.5 | 2,658.5 | 2,601.5 | 2,620 | -42 | -1.6% | 1,101,000 |
2025/08/08 | 2,667 | 2,683 | 2,614 | 2,662 | -25 | -0.9% | 1,649,800 |
2025/08/07 | 2,616 | 2,706 | 2,612.5 | 2,687 | +71 | +2.7% | 1,548,300 |
2025/08/06 | 2,557 | 2,619.5 | 2,554 | 2,616 | +46.5 | +1.8% | 959,300 |
2025/08/05 | 2,550 | 2,581 | 2,522.5 | 2,569.5 | +5 | +0.2% | 852,200 |
2025/08/04 | 2,594.5 | 2,610 | 2,546.5 | 2,564.5 | -20 | -0.8% | 1,030,300 |
2025/08/01 | 2,560 | 2,602 | 2,530 | 2,584.5 | -12.5 | -0.5% | 1,719,600 |
2025/07/31 | 2,565.5 | 2,597 | 2,558 | 2,597 | +31.5 | +1.2% | 1,290,300 |
2025/07/30 | 2,560 | 2,582 | 2,556 | 2,565.5 | -17.5 | -0.7% | 1,102,700 |
2025/07/29 | 2,550 | 2,583 | 2,540.5 | 2,583 | +9.5 | +0.4% | 1,204,800 |
2025/07/28 | 2,565 | 2,577.5 | 2,557 | 2,573.5 | +7 | +0.3% | 535,000 |
2025/07/25 | 2,584 | 2,587.5 | 2,559 | 2,566.5 | -7.5 | -0.3% | 621,300 |
2025/07/24 | 2,546 | 2,583.5 | 2,525 | 2,574 | +51.5 | +2% | 940,500 |
2025/07/23 | 2,495.5 | 2,537 | 2,481 | 2,522.5 | +43.5 | +1.8% | 1,060,300 |
2025/07/22 | 2,504.5 | 2,517.5 | 2,464 | 2,479 | -44 | -1.7% | 1,291,800 |
2025/07/18 | 2,540 | 2,540 | 2,511 | 2,523 | -13 | -0.5% | 822,300 |
2025/07/17 | 2,500 | 2,536 | 2,488 | 2,536 | +41.5 | +1.7% | 754,400 |
2025/07/16 | 2,479 | 2,501.5 | 2,476.5 | 2,494.5 | +15.5 | +0.6% | 524,000 |
2025/07/15 | 2,485 | 2,513.5 | 2,471.5 | 2,479 | +4 | +0.2% | 811,500 |
2025/07/14 | 2,467 | 2,496.5 | 2,465 | 2,475 | -5 | -0.2% | 491,800 |
2025/07/11 | 2,489.5 | 2,491.5 | 2,462.5 | 2,480 | -5.5 | -0.2% | 852,600 |
2025/07/10 | 2,499 | 2,505 | 2,473 | 2,485.5 | -21.5 | -0.9% | 1,052,600 |
2025/07/09 | 2,500 | 2,508.5 | 2,486 | 2,507 | +7 | +0.3% | 794,000 |
2025/07/08 | 2,505 | 2,512 | 2,484.5 | 2,500 | -4 | -0.2% | 1,228,700 |
2025/07/07 | 2,520 | 2,529 | 2,493.5 | 2,504 | -9 | -0.4% | 556,600 |
2025/07/04 | 2,493 | 2,513 | 2,486.5 | 2,513 | +20 | +0.8% | 797,300 |
1~
50
件表示中 / 3784件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 240,000円 | -3.5% | -11.3% | 2.50% | 22.04倍 | 1.49倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
塩野義 | 261,600円 | +20.9% | +10.6% | 2.52% | 12.37倍 | 1.63倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 518,300円 | +0.1% | -3.4% | 3.09% | 35.23倍 | 1.74倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 174,300円 | +0.6% | +43.3% | 4.59% | 12.22倍 | 1.05倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
住友ファーマ | 169,400円 | -11.0% | +206.6% | 0.00% | 16.83倍 | 3.97倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
市場注目の銘柄
チャート関連のコラム